HIAL
CAPR icon

Highland Investment Advisors LLC’s Capricor Therapeutics CAPR Stock Holding History

Highland Investment Advisors LLC’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.41K Buy
+100
New +$3.03K ﹤0.01% 482

Other funds holding CAPR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
DCM
DG Capital Management New York $475M AUM 36.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Highland Investment Advisors LLC's CAPR Position: Q2 2026 in Review

Highland Investment Advisors LLC opened a new position in Capricor Therapeutics (CAPR) in Q2 2026: 100 shares worth $2.41K. The stake represents ﹤0.01% of the portfolio and ranks #482 among its holdings.

105 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

  • Highland Investment Advisors LLC held 100 shares of Capricor Therapeutics worth $2.41K as of Q2 2026.
  • Capricor Therapeutics was a new Highland Investment Advisors LLC position in Q2 2026.
  • Capricor Therapeutics made up ﹤0.01% of Highland Investment Advisors LLC's portfolio in Q2 2026, its #482 holding.
  • 105 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on Highland Investment Advisors LLC's 13F filing for Q2 2026, filed 13 Aug 2026.